Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy

PURPOSE: National hepatitis B virus (HBV) screening recommendations for patients with cancer anticipating systemic anticancer therapy range from universal screening to screening based on risk of HBV infection, cancer therapy–specific risk of HBV reactivation, or both. We conducted cost-effectiveness...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JCO Clin Cancer Inform
Prif Awduron: Hwang, Jessica P., Huang, Danmeng, Vierling, John M., Suarez-Almazor, Maria E., Shih, Ya-Chen Tina, Chavez-MacGregor, Mariana, Duan, Zhigang, Giordano, Sharon H., Hershman, Dawn L., Fisch, Michael J., Cantor, Scott B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2019
Pynciau:
Original Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6874018/
https://ncbi.nlm.nih.gov/pubmed/30892921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.18.00097
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg